When Medications Aren't Enough: Advanced Options

When the first few medications do not stop your focal sensory seizures, it can feel like you are running out of options. However, for many people, this is actually the point where the most effective specialized evaluations become available. In the world of epilepsy care, there is a clear “fork in the road” that occurs after the second medication trial.

Defining Drug Resistance

Doctors use a very specific definition for drug-resistant epilepsy (also called medically refractory epilepsy). It is defined as the failure of two appropriately chosen and adequately dosed antiseizure medications to achieve sustained seizure freedom ^[1][2]. This implies the medications were tolerated and used with good adherence.

If you have tried two medications—such as levetiracetam and lamotrigine—at the correct doses and you are still having sensory seizures, the chance of a third or fourth medication working is low, typically between 1% and 3% ^[3]. At this stage, international guidelines recommend a prompt referral to a Comprehensive Epilepsy Center ^[4][5]. These centers have specialized teams that go beyond standard care to find a treatment strategy.

The Presurgical Evaluation: Finding the “Focus”

At a specialized center, the goal is to confirm the diagnosis and find the exact “neighborhood” in your brain where the electrical storm starts—the seizure-onset zone. Because sensory seizures can be small or deep in the brain, specialists use advanced tools ^[6]:

• Prolonged Video-EEG: You stay in the hospital for several days while cameras and EEG sensors record your brain waves during an actual seizure ^[6].
• PET and SPECT Scans: PET commonly assesses interictal glucose metabolism (between seizures), while ictal SPECT looks at how blood flows during a seizure. They can often provide vital clues even if the MRI looks normal ^[6][7].
• Stereo-EEG (sEEG): If non-invasive tests aren’t clear, doctors may suggest this procedure where tiny electrodes are placed directly into the brain to map the electrical activity with pinpoint accuracy. It is an invasive stereotactic intracranial procedure and carries risks such as hemorrhage, infection, and neurological injury ^[7].

Surgical Options

If a single, clear seizure focus is found in an area of the brain that can be safely treated, surgery may be considered.

1. Resective Surgery: This involves removing the small piece of brain tissue where the seizures start. For well-selected candidates, the success rates are much higher than for medications. In randomized trials involving selected surgical populations, seizure-freedom rates for surgery ranged from 34% to 74% (with a median of about 62%), compared to lower rates for those who only continued on medication ^[8][6]. However, a sensory focus may be close to “eloquent” areas (vital for movement, speech, or vision), and the risks of permanent neurological deficits matter heavily. Surgery is highly individualized.
2. Laser Ablation (LiTT): This is a newer option that uses a tiny laser fiber to “neutralize” the seizure focus without the need for a traditional large incision, though it is still invasive ^[9].

Neuromodulation: Managing the Storm

If the seizure focus is in a part of the brain that is too “eloquent” to remove, or if there is more than one focus, doctors may recommend neuromodulation. These are implanted devices that act like a “pacemaker for the brain.” They are palliative—meaning they reduce seizures rather than cure them ^[10].

• RNS (Responsive Neurostimulation): A “smart” device that monitors your brain waves 24/7. When it detects a programmed seizure pattern, it delivers a tiny electrical pulse to interrupt it ^[10][11]. It does not reliably prevent every subjective aura.
• VNS (Vagus Nerve Stimulation): A device implanted in the chest that sends regular pulses to the brain via the vagus nerve. It is often used when a seizure focus cannot be pinpointed ^[10][12].
• DBS (Deep Brain Stimulation): A device that sends continuous electrical signals to a specific relay station in the brain (the thalamus) to help regulate the electrical network. Selected long-term studies showed that after 7 years, patients saw a median 75% reduction in seizure frequency ^[13].

While neuromodulation is often considered “palliative”, it can significantly improve quality of life and reduce the fear of a sensory seizure evolving into a larger event ^[8][13].